Release Date: April 29, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Q: Can you provide an update on the appetite for pharmacy and Dollar stores, and your timeline for reducing exposure to Dollar General, CVS, and Walgreens? A: We aim to reduce all tenant exposures below 5% by October 31, 2025, with Walgreens targeted below 3%. There is strong interest from institutions and 1031 buyers for Dollar Stores, and we expect to continue progress in reducing exposure to Dollar General and Family Dollar. We also plan to sell some pharmacy properties before the next earnings call.
Q: What are your expectations regarding a potential ratings upgrade and the associated debt savings? A: We plan to approach rating agencies in the latter half of this year. Achieving an investment-grade credit rating could result in about 30 basis points of savings across our term loans and credit facility.
Q: Could you clarify your net investment activity and any changes in the transaction market since April 2? A: We would not increase acquisitions without an improvement in our equity price. The transaction market has not changed significantly since April 2, and we continue to see many opportunities, particularly in convenience stores, quick service restaurants, and auto service sectors.
Q: What is the status of the Big Lots asset in Maryland, and is it included in your guidance? A: We have received interest from several retailers and are negotiating attractive LOIs. We expect a better outcome by taking our time. This asset is not included in our 2025 guidance.
Q: How does the Walgreens take-private transaction affect the risk profile of those assets? A: The transaction does not change the risk profile. Sycamore's focus on retail operations and a lower leverage approach is positive. We expect Walgreens to remain a going concern, and our locations are performing well.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
This article first appeared on GuruFocus.Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.